ReviewPaediatric drugs2018
Pediatric Asthma Management in China: Current and Future Challenges.
Review in Paediatric drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis.PloS one · 2021Pooled it
- The disease burden of childhood asthma in China: a systematic review and meta-analysis.Journal of global health · 2020Pooled it
- Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis.Healthcare (Basel, Switzerland) · 2025Article
- Development and validation of asthma diagnostic scale for children.Pediatric research · 2025Article
- Article
- Temporal trends and future projections of incidence rate and mortality for asthma in China: an analysis of the Global Burden of Disease Study 2021.Frontiers in medicine · 2025Article
- Epidemiology of asthma exacerbation in children before and after the COVID-19 pandemic: a retrospective study in Chengdu, China.BMC pediatrics · 2023Article
- Causal relationship between outdoor atmospheric quality and pediatric asthma visits in hangzhou.Heliyon · 2023Article
- Article
- The Effects of Short-Term PMInternational journal of environmental research and public health · 2022Article
- A pilot study to evaluate the role of circulation CD4BMC pediatrics · 2021Article
- Sex Difference Between Trace Elements and Pulmonary Functions in Children.Biological trace element research · 2020Article
- Factors related to disagreement between self-reported versus objective measurement of allergen sensitization at a tertiary pediatric center in Beijing, China.BMC pediatrics · 2020Article
- Expression of vitamin D receptor in bronchial asthma and its bioinformatics prediction.Molecular medicine reports · 2018Article
- Neutrophil-lymphocyte ratios in blood to distinguish children with asthma exacerbation from healthy subjects.International journal of immunopathology and pharmacologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this report was to review the state of asthma diagnosis and treatment in China and to examine challenges in achieving earlier diagnosis and treatment. The prevalence of asthma in children in China has increased over past decades, and data published in 2013 indicated a prevalence of 3.0% in children aged 0-14 years. Although this prevalence has increased, the percentage of children with acute asthma attacks decreased from 86% in 2000 to 77% in 2010, and the frequency of hospitalizations for asthma attacks decreased from 54.0 to 47%. These decreases are attributed to aggressive promotion of the Global Initiative for Asthma (GINA) protocol and updated Chinese guidelines for the prevention and treatment of asthma in children. The use of inhaled corticosteroids increased and that of systemic corticosteroids decreased between 2000 and 2010. Despite these advances, a number of issues remain to be addressed. Parents lack basic knowledge of asthma and fear the use of corticosteroids. Physician education regarding the diagnosis of asthma in children aged < 6 years is lacking. Patients require training in the administration of inhaled corticosteroids and control of environmental triggers. The Chinese national guidelines for childhood asthma have been updated, but implementation remains a real challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.